The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Sep. 23, 2025
Filed:
Apr. 21, 2021
Applicant:
Neurocrine Biosciences, Inc., San Diego, CA (US);
Inventors:
Juan Pablo Cueva-Garcia, San Diego, CA (US);
Neil J. Ashweek, San Diego, CA (US);
Collin Regan, San Diego, CA (US);
Assignee:
Neurocrine Biosciences, Inc., San Diego, CA (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07D 213/56 (2006.01); C07D 213/68 (2006.01); C07D 213/69 (2006.01); C07D 213/84 (2006.01); C07D 239/26 (2006.01); C07D 401/12 (2006.01); C07D 405/12 (2006.01);
U.S. Cl.
CPC ...
C07D 213/56 (2013.01); C07D 213/68 (2013.01); C07D 213/69 (2013.01); C07D 213/84 (2013.01); C07D 239/26 (2013.01); C07D 401/12 (2013.01); C07D 405/12 (2013.01);
Abstract
The present disclosure relates to compounds of Formula (I) that modulate the activity of G-protein coupled receptor 52 (GPR52), pharmaceutically acceptable salts of compounds of Formula (I), and pharmaceutical compositions thereof. Compounds, pharmaceutical salts of compounds, and pharmaceutical compositions of the present disclosure are directed to methods useful in the treatment or prophylaxis of a neurological disease or disorder and conditions related thereto.